Skip to main content

RCP Multi-morbidity conference - Monday 1st July 2019

Cardiovascular, metabolic and kidney disease: crosscutting science and best practice Are you involved with patients who have multimorbidity? This 1-day conference, held on 1 July 2019, will look at updates in multimorbidity and the clustering of common diseases in patients.

Evoking discussion and dialogue on ways to improve the health of these patients, the conference offers a packed programme full of interactive sessions and take-home messages for direct use on the ward.

Topics covered will look at: the latest insights from industry regarding the treatment of inflammation and fibrosis; how digital health and AI are driving research on delivering personalised medicine to patients; the epidemiology of multimorbidity in vascular disease.

Hurry! Book by 20 May to receive your early-bird discount.

This unique conference to be held at the RCP aims to stimulate discussion and ideas in addressing multi-morbidity and clustering of diseases which are a major problem for health service providers. It straddles all 5 related specialties in Division 2 of the NIHR CRN portfolio, namely cardiovascular disease, stroke, diabetes, metabolic disease and nephrology. There is a need for greater integration of clinical and basic science research and pathogenetic understanding between these disease clusters, with shared treatments developed to address common pathways. The conference will be of value to clinicians, scientists and other members of the multi-professional team, as well as Pharma representatives. Please consider attending.


Cardiovascular, metabolic and kidney disease: crosscutting science and best practice in multi-morbidity

Monday 1 July 2019

Royal College of Physicians, 11 St Andrews Place, Regent’s Park, London NW1 4LE

Programme organiser: Professor Philip Kalra, Renal Association



Registration and coffee


Welcome and opening remarks
Professor Philip Kalra, Renal Association


Session 1: The challenges from a point of care perspective
Chair: Professor Philip Kalra, Renal Association


Multi-morbidity at the coal face

Professor Jackie Taylor, Royal College of Physicians and Surgeons of Glasgow


Session 2: Epidemiology and health inequalities in the multi-morbid population

Chair: Professor John Wilding, University of Liverpool


Epidemiology of multi-morbidity in the UK

Dr Dorothea Nitsch, Royal Free London NHS Foundation Trust


The healthcare providers’ perspective: current and future policy

Professor Stephen Powis, NHS England


The funder’s perspective: multi-morbidity and translating basic science into the best clinical trials

Professor Paul Elliott, Imperial College London








Session 3: Accelerating research using current data and sample resources

Chair: Professor Tom Robinson, University of Leicester


Data sets: NHS digital, UK Renal Registry, NICOR, Stroke Registry and Diabetes National Audit CPRD

Dr Fergus Caskey, University of Bristol


Research networks and existing cohorts

Professor David Wheeler, University College London



Professor Maarten Taal, University of Nottingham





Session 4: Underpinning scientific development and methodological issues

Chair: Professor Paul Cockwell, University Hospitals Birmingham


Omics potential

Professor Desmond Johnston, Imperial College Healthcare


Imaging potential

Professor Sue Francis, University of Nottingham


Devices and telemonitoring

Professor Martin Cowie, Imperial College London


Session 5: Current and future industry plans for multi-morbidity research

Chair: Dr Claire Sharpe, King’s College London


Improving multi-morbidity with newer anti-diabetic therapies

Professor John McMurray, University of Glasgow


Medicine development

Tim Johnson, UCB and Professor Robert Unwin, AstraZeneca




Session 6: UK clinical platform for multi-morbidity research

Chair: Professor John Feehally, University of Leicester and Professor Simon Heller, University of



Panel session



Proposed way forward

Professor Philip Kalra, Renal Association





Closing remarks

Professor Philip Kalra, Renal Association and Sandra Currie, Kidney Research UK


Close of conference